Managing chemotherapy-induced emesis.
Bruera
E
E
Cross Cancer Institute, Edmonton, Alberta, Canada.
Michaud
M
M
Partington
J
J
Brenneis
C
C
Paterson
A H
AH
MacDonald
R N
RN
D000970:Antineoplastic Agents / Q000009:adverse effects*; D006801:Humans; D007263:Infusions, Parenteral; D007279:Injections, Subcutaneous; D008787:Metoclopramide / Q000008:administration & dosage / Q000627:therapeutic use*; D014839:Vomiting / Q000139:chemically induced / Q000188:drug therapy*
D000970:Antineoplastic Agents; D008787:Metoclopramide